Description

Celoda (capecitabine) coated tablets 500 mg. №120

Ingredients

Each coated tablet contains 500 mg of capecitabine.

Dosage

The recommended dosage is determined by the prescribing healthcare provider based on individual factors.

Indications

Celoda is indicated for the treatment of:

• Colorectal cancer
• Breast cancer

Contraindications

Do not use Celoda if you have:

• Known severe hypersensitivity to capecitabine or fluorouracil
• Dihydropyrimidine dehydrogenase (DPD) deficiency

Directions

Take Celoda exactly as prescribed by your healthcare provider.

Scientific Evidence

Celoda (capecitabine) has shown significant efficacy in the treatment of colorectal and breast cancer. Research studies have demonstrated its ability to convert to 5-fluorouracil, a cytotoxic agent, preferentially in tumor cells, leading to tumor regression and improved survival rates.

Clinical trials have shown that Celoda is well-tolerated and effective as a monotherapy or in combination with other cancer treatments. Patients receiving Celoda have experienced manageable side effects, with the benefits outweighing the risks in most cases.